wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33387073-3B2C925B-7AF9-4536-AA9A-51A5C8358BC5
Q33387073-3B2C925B-7AF9-4536-AA9A-51A5C8358BC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33387073-3B2C925B-7AF9-4536-AA9A-51A5C8358BC5
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinib.
P2860
Q33387073-3B2C925B-7AF9-4536-AA9A-51A5C8358BC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33387073-3B2C925B-7AF9-4536-AA9A-51A5C8358BC5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7ddf8615cd538c0e070f8bcfe43441455b1bfce9
P2860
Targeted therapy for advanced renal cell carcinoma